Beta Drugs (NSE:BETA) Buildings And Improvements : ₹0 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Beta Drugs Buildings And Improvements?

Beta Drugs's quarterly buildings and improvements declined from Mar. 2024 (₹314 Mil) to Sep. 2024 (₹0 Mil) but then stayed the same from Sep. 2024 (₹0 Mil) to Mar. 2025 (₹0 Mil).

Beta Drugs's annual buildings and improvements increased from Mar. 2023 (₹281 Mil) to Mar. 2024 (₹314 Mil) but then declined from Mar. 2024 (₹314 Mil) to Mar. 2025 (₹0 Mil).

Beta Drugs Buildings And Improvements Historical Data

The historical data trend for Beta Drugs's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beta Drugs Buildings And Improvements Chart

Beta Drugs Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Buildings And Improvements

Get a 7-Day Free Trial

172.15

244.20

280.94

314.39

Beta Drugs Semi-Annual Data
	Mar14	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
Buildings And Improvements	Get a 7-Day Free Trial															280.94	-	314.39	-	-

Beta Drugs Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Beta Drugs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beta Drugs Ltd (NSE:BETA) » Definitions » Buildings And Improvements

Traded in Other Exchanges

N/A

Address

SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114

Website

https://www.betadrugslimited.com

Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports them to other countries of which key revenue is derived from the sales made in India.

Beta Drugs Headlines

No Headlines